These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31023374)

  • 1. A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies.
    Liatis S; Iraklianou S; Kazakos K; Mastorakos G; Milios K; Mouslech Z; Noutsou M; Pagkalos E; Sampanis C;
    BMC Endocr Disord; 2019 Apr; 19(1):39. PubMed ID: 31023374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry.
    Souliotis K; Koutsovasilis A; Vatheia G; Golna C; Nikolaidi S; Hatziagelaki E; Kotsa K; Koufakis T; Melidonis A; Papazafiropoulou A; Tentolouris N; Siami E; Sotiropoulos A
    BMC Endocr Disord; 2020 Jan; 20(1):16. PubMed ID: 31992275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT).
    Gao L; Zhang P; Weng J; Lu J; Guo X; Jia W; Yang W; Zou D; Zhou Z; Pan C; Gao Y; Li X; Zhu D; Wu Y; Garg SK; Ji L
    J Diabetes; 2020 Sep; 12(9):668-676. PubMed ID: 32329194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, epidemiological study of the treatment patterns, comorbidities and hypoglycemia events of patients with type 2 diabetes and moderate or severe chronic kidney disease - the 'LEARN' study.
    Rombopoulos G; Panitti E; Varounis C; Katsinas C; Stefanidis I; Goumenos D
    Curr Med Res Opin; 2016 May; 32(5):939-47. PubMed ID: 26857244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
    Datta-Nemdharry P; Thomson A; Beynon J; Donegan K
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualised treatment targets in patients with type-2 diabetes and hypertension.
    Schmieder RE; Tschöpe D; Koch C; Ouarrak T; Gitt AK;
    Cardiovasc Diabetol; 2018 Jan; 17(1):18. PubMed ID: 29357854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of diabetes treatment with long-term glycemic patterns in patients with type 2 diabetes mellitus: A prospective cohort study.
    Luo M; Tan CS; Lim WY; Chia KS; Tang WE; Tai ES; Venkataraman K
    Diabetes Metab Res Rev; 2019 May; 35(4):e3122. PubMed ID: 30600922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing variability in compliance with recommendations given by the International Diabetes Federation (IDF) for patients with type 2 diabetes in primary care using electronic records. The APNA study.
    Brugos-Larumbe A; Aldaz-Herce P; Guillen-Grima F; Garjón-Parra FJ; Bartolomé-Resano FJ; Arizaleta-Beloqui MT; Pérez-Ciordia I; Fernández-Navascués AM; Lerena-Rivas MJ; Berjón-Reyero J; Jusué-Rípodas L; Aguinaga-Ontoso I
    Prim Care Diabetes; 2018 Feb; 12(1):34-44. PubMed ID: 28732655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An observational, multicentre study on different insulin glargine U100 titration algorithms used in patients with type 2 diabetes in daily medical practice in Adriatic countries: The ADRESA study.
    Krnić M; Marolt I; Skelin M; Grulović N; Rahelić D
    Diabetes Res Clin Pract; 2019 Apr; 150():144-149. PubMed ID: 30641166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2-Grupa study.
    Bała MM; Płaczkiewicz-Jankowska E; Leśniak W; Topór-Mądry R; Michałejko M; Jankowski M; Strzeszyński L; Sieradzki J; Czupryniak L;
    Pol Arch Med Wewn; 2013; 123(11):573-81. PubMed ID: 24241157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to insulin initiation in elderly patients with type 2 diabetes mellitus in Brazil.
    Eliaschewitz FG; de Paula MA; Pedrosa HC; Pires AC; Salles JEN; Tambascia MA; A Turatti LA
    Diabetes Metab Syndr; 2018; 12(1):39-44. PubMed ID: 28864058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK.
    Boye KS; Stein D; Matza LS; Jordan J; Yu R; Norrbacka K; Hassan SW; García-Pérez LE
    Drugs R D; 2019 Jun; 19(2):213-225. PubMed ID: 31115873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.
    Mata-Cases M; Franch-Nadal J; Real J; Gratacòs M; López-Simarro F; Khunti K; Mauricio D
    Diabetes Obes Metab; 2018 Jan; 20(1):103-112. PubMed ID: 28656746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrospective analysis.
    Burgmann K; Fatio S; Jordi B; Rutishauser J
    Swiss Med Wkly; 2013; 143():w13871. PubMed ID: 24163110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
    Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
    Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to national diabetes guidelines through monitoring quality indicators--A comparison of three types of care for the elderly with special emphasis on HbA1c.
    Neumark AS; Brudin L; Neumark T
    Prim Care Diabetes; 2015 Aug; 9(4):253-60. PubMed ID: 25865853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.